Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker

Oncotarget
Ana Batlle-LópezSantiago Montes-Moreno

Abstract

Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be classified into three molecular subtypes by gene expression profiling (GEP): GCB, ABC and unclassified. Immunohistochemistry-based cell of origin (COO) classification, as a surrogate for GEP, using three available immunohistochemical algorithms was evaluated in TMA-arranged tissue samples from 297 patients with de novo DLBCL treated by chemoimmunotherapy (R-CHOP and R-CHOP-like regimens). Additionally, the prognostic impacts of MYC, BCL2, IRF4 and BCL6 abnormalities detected by FISH, the relationship between the immunohistochemical COO classification and the immunohistochemical expression of MYC, BCL2 and pSTAT3 proteins and clinical data were evaluated. In our series, non-GCB DLBCL patients had significantly worse progression-free survival (PFS) and overall survival (OS), as calculated using the Choi, Visco-Young and Hans algorithms, indicating that any of these algorithms would be appropriate for identifying patients who require alternative therapies to R-CHOP. Whilst MYC abnormalities had no impact on clinical outcome in the non-GCB subtype, those patients with isolated MYC rearrangements and a GCB-DLBCL phenotype had worse PFS...Continue Reading

References

Jul 14, 1994·The New England Journal of Medicine·K OffitA Rosenbaum
Jan 5, 1999·The Journal of Experimental Medicine·N KiuchiT Hirano
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Apr 29, 2006·The Journal of Molecular Diagnostics : JMD·Roland A VenturaReiner Siebert
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gustaaf W van ImhoffPhilip M Kluin
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William W L ChoiWing C Chan
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christiane Copie-BergmanThierry J Molina
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marita ZiepertMarkus Loeffler
May 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharon BarransAndrew Jack
Dec 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul N MeyerDennis D Weisenburger
Mar 29, 2011·Blood·Gonzalo Gutiérrez-GarcíaUNKNOWN Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
Jun 3, 2011·Blood·Santiago Montes-MorenoMiguel A Piris
Sep 6, 2011·Cell·Jake E DelmoreConstantine S Mitsiades
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jennifer A MertzRobert J Sims
Oct 18, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Shaoying LiL Jeffrey Medeiros
Dec 2, 2011·Journal of Clinical Pathology·Andrea Sartore-BianchiSalvatore Siena
Jun 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tina Marie GreenMichael Boe Møller
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nathalie A JohnsonRandy D Gascoyne
Aug 23, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M Dolores DelgadoJavier León
Oct 2, 2012·Molecular Diagnosis & Therapy·Lloyd T LamBrenda Chyla
Jan 22, 2013·Blood·Heike HornUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group
Apr 5, 2014·Trends in Molecular Medicine·Katerina Hatzi, Ari Melnick
Apr 8, 2014·The Oncologist·Javier MunozDavid S Hong
Aug 16, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi Young OkKen H Young
Aug 20, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grzegorz S NowakowskiThomas E Witzig

❮ Previous
Next ❯

Citations

Sep 3, 2016·Epigenomics·Wallax Augusto Silva FerreiraBárbara do Nascimento Borges
Aug 31, 2019·British Journal of Haematology·Laure PhilippeUNKNOWN ANRS-CO16 LYMPHOVIR Cohort
Dec 1, 2019·European Journal of Haematology·Maysaa AbdullaRose-Marie Amini
May 29, 2018·La Revue de médecine interne·C Rossi, J N Bastie
May 10, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Sarkozy, B Coiffier

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
xenograft

Software Mentioned

GEP

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.